Loading…
A modified technique for measurement of nasal transepithelial potential difference in infants
Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 wi...
Saved in:
Published in: | The Journal of pediatrics 2001-09, Vol.139 (3), p.353-358 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3 |
container_end_page | 358 |
container_issue | 3 |
container_start_page | 353 |
container_title | The Journal of pediatrics |
container_volume | 139 |
creator | Southern, Kevin W. Noone, Peadar G. Bosworth, Darin G. LeGrys, Vicky A. Knowles, Michael R. Barker, Pierre M. |
description | Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 with cystic fibrosis [CF]). Nasal PD was measured in 13 infants with a possible diagnosis of CF. Results: Recordings were similar for the established and the modified methods in adult volunteers. An amiloride concentration of 10–4 mol/L was necessary for full inhibition of amiloride-sensitive sodium ion (Na+) transport. Of the 13 infants, 2 had PD values suggestive of CF (mean baseline PD, –50.1 mV and –31.4 mV; maximum baseline PD, –61 mV and –49 mV; change in PD after perfusion with zero chloride solution with isoprenaline and amiloride [ΔzeroCl–/Iso], –1 mV and +3.5 mV), and 11 had normal values (mean ± SEM baseline PD, –13.2 ± 1.0 mV; maximum baseline PD, –21.4 ± 2.0; ΔzeroCl–/Iso, –15.3 ± 1.9 mV). These results correlated with subsequent sweat test data, mutation analysis, and clinical outcome. Conclusion: Nasal PD measured with this modified method is comparable to that measured with an established adult method. The measurements were well tolerated in 13 infants and discriminated bioelectric profiles characteristic of normal and CF respiratory epithelium. This study supports the use of this modified nasal PD technique as a diagnostic test for CF in newborn infants. (J Pediatr 2001;139:353-8) |
doi_str_mv | 10.1067/mpd.2001.116278 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71173505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002234760195173X</els_id><sourcerecordid>71173505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3</originalsourceid><addsrcrecordid>eNp1kMtLAzEQh4Motj7O3mRP3rbOJN2kexTxBQUvepSQzU5oZF8mqeB_b0oLnoSBzDBffiQfY1cICwSpbvupXXAAXCBKrlZHbI5Qq1KuhDhmcwDOS7FUcsbOYvwEgHoJcMpmiJXkEsWcfdwV_dh656ktEtnN4L-2VLgxFD2ZuA3U05CK0RWDiaYrUjBDpMmnDXU-z9OY8n7X5QxHgQZLhR9yOTOkeMFOnOkiXR7Oc_b--PB2_1yuX59e7u_WpRVLkUpZ1_XKusYKFHJplalBAXe8IcdXSNiiaMDxtiKhbGVVLRoliWyDjQVXOXHObva5Uxjz-2PSvY-Wus4MNG6jVohKVFBl8HYP2jDGGMjpKfjehB-NoHdGdTaqd0b13mi-cX2I3jY9tX_8QWEG6j1A-YPfnoKO1u88tD6QTbod_b_hv4y8hpE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71173505</pqid></control><display><type>article</type><title>A modified technique for measurement of nasal transepithelial potential difference in infants</title><source>ScienceDirect Freedom Collection</source><creator>Southern, Kevin W. ; Noone, Peadar G. ; Bosworth, Darin G. ; LeGrys, Vicky A. ; Knowles, Michael R. ; Barker, Pierre M.</creator><creatorcontrib>Southern, Kevin W. ; Noone, Peadar G. ; Bosworth, Darin G. ; LeGrys, Vicky A. ; Knowles, Michael R. ; Barker, Pierre M.</creatorcontrib><description>Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 with cystic fibrosis [CF]). Nasal PD was measured in 13 infants with a possible diagnosis of CF. Results: Recordings were similar for the established and the modified methods in adult volunteers. An amiloride concentration of 10–4 mol/L was necessary for full inhibition of amiloride-sensitive sodium ion (Na+) transport. Of the 13 infants, 2 had PD values suggestive of CF (mean baseline PD, –50.1 mV and –31.4 mV; maximum baseline PD, –61 mV and –49 mV; change in PD after perfusion with zero chloride solution with isoprenaline and amiloride [ΔzeroCl–/Iso], –1 mV and +3.5 mV), and 11 had normal values (mean ± SEM baseline PD, –13.2 ± 1.0 mV; maximum baseline PD, –21.4 ± 2.0; ΔzeroCl–/Iso, –15.3 ± 1.9 mV). These results correlated with subsequent sweat test data, mutation analysis, and clinical outcome. Conclusion: Nasal PD measured with this modified method is comparable to that measured with an established adult method. The measurements were well tolerated in 13 infants and discriminated bioelectric profiles characteristic of normal and CF respiratory epithelium. This study supports the use of this modified nasal PD technique as a diagnostic test for CF in newborn infants. (J Pediatr 2001;139:353-8)</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1067/mpd.2001.116278</identifier><identifier>PMID: 11562613</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Adult ; Amiloride ; Cystic Fibrosis - diagnosis ; Cystic Fibrosis - genetics ; Differential Threshold ; Diuretics ; Genotype ; Humans ; Infant ; Infant, Newborn ; Nasal Mucosa</subject><ispartof>The Journal of pediatrics, 2001-09, Vol.139 (3), p.353-358</ispartof><rights>2001 Mosby, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3</citedby><cites>FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11562613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Southern, Kevin W.</creatorcontrib><creatorcontrib>Noone, Peadar G.</creatorcontrib><creatorcontrib>Bosworth, Darin G.</creatorcontrib><creatorcontrib>LeGrys, Vicky A.</creatorcontrib><creatorcontrib>Knowles, Michael R.</creatorcontrib><creatorcontrib>Barker, Pierre M.</creatorcontrib><title>A modified technique for measurement of nasal transepithelial potential difference in infants</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 with cystic fibrosis [CF]). Nasal PD was measured in 13 infants with a possible diagnosis of CF. Results: Recordings were similar for the established and the modified methods in adult volunteers. An amiloride concentration of 10–4 mol/L was necessary for full inhibition of amiloride-sensitive sodium ion (Na+) transport. Of the 13 infants, 2 had PD values suggestive of CF (mean baseline PD, –50.1 mV and –31.4 mV; maximum baseline PD, –61 mV and –49 mV; change in PD after perfusion with zero chloride solution with isoprenaline and amiloride [ΔzeroCl–/Iso], –1 mV and +3.5 mV), and 11 had normal values (mean ± SEM baseline PD, –13.2 ± 1.0 mV; maximum baseline PD, –21.4 ± 2.0; ΔzeroCl–/Iso, –15.3 ± 1.9 mV). These results correlated with subsequent sweat test data, mutation analysis, and clinical outcome. Conclusion: Nasal PD measured with this modified method is comparable to that measured with an established adult method. The measurements were well tolerated in 13 infants and discriminated bioelectric profiles characteristic of normal and CF respiratory epithelium. This study supports the use of this modified nasal PD technique as a diagnostic test for CF in newborn infants. (J Pediatr 2001;139:353-8)</description><subject>Adult</subject><subject>Amiloride</subject><subject>Cystic Fibrosis - diagnosis</subject><subject>Cystic Fibrosis - genetics</subject><subject>Differential Threshold</subject><subject>Diuretics</subject><subject>Genotype</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Nasal Mucosa</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kMtLAzEQh4Motj7O3mRP3rbOJN2kexTxBQUvepSQzU5oZF8mqeB_b0oLnoSBzDBffiQfY1cICwSpbvupXXAAXCBKrlZHbI5Qq1KuhDhmcwDOS7FUcsbOYvwEgHoJcMpmiJXkEsWcfdwV_dh656ktEtnN4L-2VLgxFD2ZuA3U05CK0RWDiaYrUjBDpMmnDXU-z9OY8n7X5QxHgQZLhR9yOTOkeMFOnOkiXR7Oc_b--PB2_1yuX59e7u_WpRVLkUpZ1_XKusYKFHJplalBAXe8IcdXSNiiaMDxtiKhbGVVLRoliWyDjQVXOXHObva5Uxjz-2PSvY-Wus4MNG6jVohKVFBl8HYP2jDGGMjpKfjehB-NoHdGdTaqd0b13mi-cX2I3jY9tX_8QWEG6j1A-YPfnoKO1u88tD6QTbod_b_hv4y8hpE</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>Southern, Kevin W.</creator><creator>Noone, Peadar G.</creator><creator>Bosworth, Darin G.</creator><creator>LeGrys, Vicky A.</creator><creator>Knowles, Michael R.</creator><creator>Barker, Pierre M.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010901</creationdate><title>A modified technique for measurement of nasal transepithelial potential difference in infants</title><author>Southern, Kevin W. ; Noone, Peadar G. ; Bosworth, Darin G. ; LeGrys, Vicky A. ; Knowles, Michael R. ; Barker, Pierre M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Amiloride</topic><topic>Cystic Fibrosis - diagnosis</topic><topic>Cystic Fibrosis - genetics</topic><topic>Differential Threshold</topic><topic>Diuretics</topic><topic>Genotype</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Nasal Mucosa</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Southern, Kevin W.</creatorcontrib><creatorcontrib>Noone, Peadar G.</creatorcontrib><creatorcontrib>Bosworth, Darin G.</creatorcontrib><creatorcontrib>LeGrys, Vicky A.</creatorcontrib><creatorcontrib>Knowles, Michael R.</creatorcontrib><creatorcontrib>Barker, Pierre M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Southern, Kevin W.</au><au>Noone, Peadar G.</au><au>Bosworth, Darin G.</au><au>LeGrys, Vicky A.</au><au>Knowles, Michael R.</au><au>Barker, Pierre M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A modified technique for measurement of nasal transepithelial potential difference in infants</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>139</volume><issue>3</issue><spage>353</spage><epage>358</epage><pages>353-358</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><abstract>Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 with cystic fibrosis [CF]). Nasal PD was measured in 13 infants with a possible diagnosis of CF. Results: Recordings were similar for the established and the modified methods in adult volunteers. An amiloride concentration of 10–4 mol/L was necessary for full inhibition of amiloride-sensitive sodium ion (Na+) transport. Of the 13 infants, 2 had PD values suggestive of CF (mean baseline PD, –50.1 mV and –31.4 mV; maximum baseline PD, –61 mV and –49 mV; change in PD after perfusion with zero chloride solution with isoprenaline and amiloride [ΔzeroCl–/Iso], –1 mV and +3.5 mV), and 11 had normal values (mean ± SEM baseline PD, –13.2 ± 1.0 mV; maximum baseline PD, –21.4 ± 2.0; ΔzeroCl–/Iso, –15.3 ± 1.9 mV). These results correlated with subsequent sweat test data, mutation analysis, and clinical outcome. Conclusion: Nasal PD measured with this modified method is comparable to that measured with an established adult method. The measurements were well tolerated in 13 infants and discriminated bioelectric profiles characteristic of normal and CF respiratory epithelium. This study supports the use of this modified nasal PD technique as a diagnostic test for CF in newborn infants. (J Pediatr 2001;139:353-8)</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>11562613</pmid><doi>10.1067/mpd.2001.116278</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3476 |
ispartof | The Journal of pediatrics, 2001-09, Vol.139 (3), p.353-358 |
issn | 0022-3476 1097-6833 |
language | eng |
recordid | cdi_proquest_miscellaneous_71173505 |
source | ScienceDirect Freedom Collection |
subjects | Adult Amiloride Cystic Fibrosis - diagnosis Cystic Fibrosis - genetics Differential Threshold Diuretics Genotype Humans Infant Infant, Newborn Nasal Mucosa |
title | A modified technique for measurement of nasal transepithelial potential difference in infants |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T22%3A48%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20modified%20technique%20for%20measurement%20of%20nasal%20transepithelial%20potential%20difference%20in%20infants&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Southern,%20Kevin%20W.&rft.date=2001-09-01&rft.volume=139&rft.issue=3&rft.spage=353&rft.epage=358&rft.pages=353-358&rft.issn=0022-3476&rft.eissn=1097-6833&rft_id=info:doi/10.1067/mpd.2001.116278&rft_dat=%3Cproquest_cross%3E71173505%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71173505&rft_id=info:pmid/11562613&rfr_iscdi=true |